TD Waterhouse Canada’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.54M Buy
21,952
+19,845
+942% +$4.94M 0.02% 364
2025
Q4
$580K Sell
2,107
-17
-0.8% -$4.65K ﹤0.01% 665
2025
Q3
$575K Buy
2,124
+49
+2% +$11.9K ﹤0.01% 649
2025
Q2
$461K Buy
2,075
+41
+2% +$8.77K ﹤0.01% 673
2025
Q1
$448K Sell
2,034
-207
-9% -$57K ﹤0.01% 652
2024
Q4
$734K Buy
2,241
+347
+18% +$109K 0.01% 558
2024
Q3
$567K Sell
1,894
-2,662
-58% -$815K ﹤0.01% 594
2024
Q2
$1.48M Sell
4,556
-171
-4% -$60.4K 0.01% 419
2024
Q1
$1.88M Buy
4,727
+461
+11% +$171K 0.01% 400
2023
Q4
$1.49M Buy
4,266
+144
+3% +$51K 0.01% 366
2023
Q3
$1.56M Buy
4,122
+1,535
+59% +$594K 0.02% 351
2023
Q2
$1M Buy
2,587
+32
+1% +$11.4K 0.01% 412
2023
Q1
$907K Buy
2,555
+1,393
+120% +$407K 0.01% 429
2022
Q4
$274K Buy
1,162
+364
+46% +$86.3K ﹤0.01% 609
2022
Q3
$205K Buy
798
+344
+76% +$105K ﹤0.01% 665
2022
Q2
$141K Buy
454
+442
+3,683% +$144K ﹤0.01% 732
2022
Q1
$5K Sell
12
-7,334
-100% -$2.87M ﹤0.01% 1449
2021
Q4
$3.83M Buy
+7,346
New +$3.16M 0.04% 253

Other funds holding WST